多巴胺神经元的重复化学遗传激活会导致基线和安非他命诱导的行为发生可逆变化
Muhammad O Chohan1,2, Halli Fein3,4, Sarah Mirro3,4
1Department of Psychiatry, Columbia University Medical Center, New York, NY, 10032, USA. muhammad.chohan@nyspi.columbia.edu.
Psychopharmacology
|August 18, 2023
概括
多巴胺神经元与DREADDs的重复化学遗传激活会导致恒温变化,减少运动和安非他胺反应. 这些神经适应效应在洗后会逆转,突出显示需要在研究中考虑它们.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 使用专门由设计药物 (DREADDs) 激活的设计受体进行化学遗传刺激是研究神经回路的常见方法.
- 由于重复使用DREADD激动剂,潜在的恒温适应性尚未得到充分了解.
- 研究这些适应对于解释基于DREADD的研究成果至关重要.
研究的目的:
- 评估多巴胺基 (DA) 神经元的重复DREADD激活对行为和神经元活动的影响.
- 为了确定重复使用DREADD是否会诱导类似于基因操纵的补偿性变化.
- 为了评估这些效应在洗期后的可逆性.
主要方法:
- 在成年TH-Cre小鼠中表达了刺激性hM3D ((Gq) DREADDs.
- 小鼠接受了克洛扎N-氧化物 (CNO) 的重复治疗.
- 评估了运动,刻板印象和DA神经元发射,以及对安非他命 (AMPH) 的反应.
主要成果:
- 在表达DREADD的小鼠中,重复的CNO给药降低了基底运动和AMPH诱导的行为.
- 经过重复的CNO暴露,DA神经元的激发率降低了.
- 一个为期两个月的CNO洗期恢复了正常的运动和AMPH反应.
结论:
- 重复激活DA神经元的DREADD会诱导显著的恒常适应.
- 这些神经适应性变化会影响行为反应和神经元活动.
- 这些发现强调了在电路和行为研究中考虑慢性DREADD效应的重要性.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
1.4K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
234
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
234
Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K
Drug Abuse and Addiction: Pharmacological Phenomena
512
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
512


